TrialThe Journal of urology2026

Three-Year Efficacy and Safety of Revi Implantable Tibial Neuromodulation from the Pivotal OASIS Study.

Cindy L Amundsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.